Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$8.76 - $11.92 $1.85 Million - $2.52 Million
-211,571 Reduced 91.52%
19,597 $180,000
Q1 2023

May 11, 2023

BUY
$10.44 - $12.49 $2.24 Million - $2.68 Million
214,480 Added 1285.23%
231,168 $2.56 Million
Q4 2022

Feb 07, 2023

BUY
$8.01 - $11.35 $15,635 - $22,155
1,952 Added 13.25%
16,688 $177,000
Q3 2022

Nov 10, 2022

BUY
$6.25 - $8.94 $18,193 - $26,024
2,911 Added 24.62%
14,736 $122,000
Q2 2022

Aug 03, 2022

BUY
$6.24 - $7.44 $73,788 - $87,978
11,825 New
11,825 $80,000
Q1 2022

May 04, 2022

SELL
$5.73 - $7.81 $89,972 - $122,632
-15,702 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$5.3 - $6.3 $83,220 - $98,922
15,702 New
15,702 $94,000
Q3 2020

Oct 09, 2020

SELL
$2.36 - $4.64 $32,362 - $63,628
-13,713 Closed
0 $0
Q2 2020

Jul 08, 2020

BUY
$2.09 - $3.05 $28,660 - $41,824
13,713 New
13,713 $34,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $89.6M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.